The estimated Net Worth of Ix Lp Seventh Mdv Partners,... is at least 37.7 百万$ dollars as of 14 September 2016. Ix Partners owns over 62,977 units of Adamas Pharmaceuticals Inc stock worth over 33,141,429$ and over the last 10 years Ix sold ADMS stock worth over 4,552,530$.
Ix has made over 11 trades of the Adamas Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Ix bought 62,977 units of ADMS stock worth 1,037,861$ on 14 September 2016.
The largest trade Ix's ever made was selling 119,556 units of Adamas Pharmaceuticals Inc stock on 28 May 2015 worth over 2,154,399$. On average, Ix trades about 43,859 units every 50 days since 2015. As of 14 September 2016 Ix still owns at least 4,031,804 units of Adamas Pharmaceuticals Inc stock.
You can see the complete history of Ix Partners stock trades at the bottom of the page.
Over the last 11 years, insiders at Adamas Pharmaceuticals Inc have traded over 26,222,162$ worth of Adamas Pharmaceuticals Inc stock and bought 1,128,061 units worth 17,799,399$ . The most active insiders traders include Point Partners Llcjay Jeffr...、David L Mahoney、William W. Ericson. On average, Adamas Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of 254,236$. The most recent stock trade was executed by Vijay Shreedhar on 21 June 2021, trading 6,200 units of ADMS stock currently worth 31,992$.
Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.
Adamas Pharmaceuticals Inc executives and other stock owners filed with the SEC include: